By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer today announced two acquisitions totaling $220 million in aggregate to expand its informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

The Waltham, Mass.-based firm has signed a definitive agreement to acquire CambridgeSoft in one deal and completed its purchase of ArtusLabs in the other. The CambridgeSoft acquisition is expected to close in the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.